Literature DB >> 10505505

Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury.

E Kaptanoglu1, H H Caner, H S Sürücü, F Akbiyik.   

Abstract

OBJECT: The purpose of this study was to investigate the effect of mexiletine on lipid peroxidation and on ultrastructural findings after induced spinal cord injury (SCI). The authors also compared the activity of mexiletine to that of the well-known antioxidant, methylprednisolone sodium succinate (MPSS).
METHODS: Wistar rats were divided into seven groups, (Groups 1-7). Those in Groups 1 and 2 were control animals that underwent laminectomy only, after which nontraumatized spinal cord samples were obtained immediately (Group 1) and 2 hours postsurgery (Group 2). Spinal cord injury was induced in all other groups, and cord samples were obtained at 2 hours postsurgery. The rats in Group 3 underwent SCI alone; those in Group 4 received 30 mg/kg of MPSS intraperitoneally immediately after trauma was induced; and those in Groups 5, 6, and 7 received 1, 10, and 50 mg/kg of mexiletine, respectively, by intraperitoneal injection immediately after trauma was induced. Compared with the levels in control animals, lipid peroxidation was significantly elevated in rats in Groups 3 and 5, but there were no statistical differences among those in Groups 1, 2, 4, 6 and 7 in this regard. Compared with the findings in rats in Group 3, ultrastructural damage post-SCI was minor in rats in Groups 4 and 5, and there was even less damage evident in rats in Group 7.
CONCLUSIONS: Analysis of these findings showed that administration of 50 mg/kg mexiletine significantly decreased the level of lipid peroxidation and protected spinal cord ultrastructure following SCI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505505     DOI: 10.3171/spi.1999.91.2.0200

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  The antioxidant effect of beta-Glucan on oxidative stress status in experimental spinal cord injury in rats.

Authors:  Hakan Kayali; M Fatih Ozdag; Serdar Kahraman; Ahmet Aydin; Engin Gonul; Ahmet Sayal; Zeki Odabasi; Erdener Timurkaynak
Journal:  Neurosurg Rev       Date:  2005-04-30       Impact factor: 3.042

3.  Effects of mexiletine, ginkgo biloba extract (EGb 761), and their combination on experimental head injury.

Authors:  Ahmet Menkü; R Kemal Koç; Vatan Tayfur; Recep Saraymen; Figen Narin; Hidayet Akdemir
Journal:  Neurosurg Rev       Date:  2003-07-12       Impact factor: 3.042

4.  Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results.

Authors:  Erkan Kaptanoglu; Etem Beskonakli; Ihsan Solaroglu; Asuman Kilinc; Yamac Taskin
Journal:  Neurosurg Rev       Date:  2003-05-29       Impact factor: 3.042

5.  Neuroprotective effect of mexiletine in the central nervous system of diabetic rats.

Authors:  Ozkan Ates; Suleyman R Cayli; Eyup Altinoz; Neslihan Yucel; Ayhan Kocak; Ozcan Tarim; Akif Durak; Yusuf Turkoz; Saim Yologlu
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

6.  Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.

Authors:  Suleyman R Cayli; Ayhan Kocak; Ugur Yilmaz; Ayhan Tekiner; Mine Erbil; Cetin Ozturk; Kadir Batcioglu; Saim Yologlu
Journal:  Eur Spine J       Date:  2004-07-01       Impact factor: 3.134

7.  Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings.

Authors:  Erkan Kaptanoglu; Ihsan Solaroglu; Ozerk Okutan; H Selcuk Surucu; Filiz Akbiyik; Etem Beskonakli
Journal:  Neurosurg Rev       Date:  2003-08-14       Impact factor: 3.042

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.